A. Durmanova, Gulnur Slyamova, M. Rakhimzhanova, A. Gusmanov, Gulmira Zhakanova, Gulmira Abduakhassova, Assel Issabayeva, Assiya Nurgaliyeva, Alina Alzhaxina, Aigerim Umerzakova, Kristina Fedoskina, Marina Kalzhanova, Makhabbat Serikbayeva, Altay Nabiyev, A. Gaipov
{"title":"Glycemic control in children with type 1 diabetes: Insulin pump therapy versus multiple daily injections","authors":"A. Durmanova, Gulnur Slyamova, M. Rakhimzhanova, A. Gusmanov, Gulmira Zhakanova, Gulmira Abduakhassova, Assel Issabayeva, Assiya Nurgaliyeva, Alina Alzhaxina, Aigerim Umerzakova, Kristina Fedoskina, Marina Kalzhanova, Makhabbat Serikbayeva, Altay Nabiyev, A. Gaipov","doi":"10.29333/ejgm/14403","DOIUrl":null,"url":null,"abstract":"While many studies compared multiple daily injections (MDI) and insulin pump therapy on various clinical outcomes, the results remain inconclusive. This multicenter retrospective cohort study included 175 patients and aimed to evaluate the effects of different insulin therapy methods on various clinical outcomes, including hemoglobin A1c (HbA1c), total daily insulin dosage, body mass index, glomerular filtration rate, in pediatric patients with type 1 diabetes. In a linear mixed-effects regression analysis, a statistically significant interaction between time and treatment type on HbA1c was found. It suggested significantly higher reduction of HbA1c values between 12-month visit and baseline in the group receiving MDIs compared to insulin pump therapy. Patients using MDIs observed higher reduction of HbA1c levels and lower total daily insulin dose relative to insulin pump therapy group. Other changes of clinical indicators were the same for group of patients. Various studies report controversial results on long term effects of these treatments on HbA1c values necessitating large population-based cohort studies in this field.","PeriodicalId":44930,"journal":{"name":"Electronic Journal of General Medicine","volume":null,"pages":null},"PeriodicalIF":1.0000,"publicationDate":"2024-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Electronic Journal of General Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29333/ejgm/14403","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
While many studies compared multiple daily injections (MDI) and insulin pump therapy on various clinical outcomes, the results remain inconclusive. This multicenter retrospective cohort study included 175 patients and aimed to evaluate the effects of different insulin therapy methods on various clinical outcomes, including hemoglobin A1c (HbA1c), total daily insulin dosage, body mass index, glomerular filtration rate, in pediatric patients with type 1 diabetes. In a linear mixed-effects regression analysis, a statistically significant interaction between time and treatment type on HbA1c was found. It suggested significantly higher reduction of HbA1c values between 12-month visit and baseline in the group receiving MDIs compared to insulin pump therapy. Patients using MDIs observed higher reduction of HbA1c levels and lower total daily insulin dose relative to insulin pump therapy group. Other changes of clinical indicators were the same for group of patients. Various studies report controversial results on long term effects of these treatments on HbA1c values necessitating large population-based cohort studies in this field.